Stopping when the experimental regimen does not appear to help
Author:
Publisher
Wiley
Subject
Statistics and Probability,Epidemiology
Reference9 articles.
1. Chemotherapy in pancreatic cancer: results of a controlled, prospective, randomised, multicentre trial.
2. A phase III trial on the therapy of advanced pancreatic carcinoma evaluations of the mallinson regimen and combined 5-fluorouracil, doxorubicin, and cisplatin
3. An aid to data monitoring in long-term clinical trials
Cited by 76 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Futility monitoring for randomized clinical trials with non-proportional hazards: An optimal conditional power approach;Clinical Trials;2023-06-27
2. Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer;New England Journal of Medicine;2023-06-08
3. Final survival analysis of topotecan and paclitaxel for first-line treatment of advanced cervical cancer: An NRG oncology randomized study;Gynecologic Oncology;2023-04
4. Design of phase II oncology trials evaluating combinations of experimental agents;JNCI: Journal of the National Cancer Institute;2023-03-21
5. National Cancer Institute Combination Therapy Platform Trial with Molecular Analysis for Therapy Choice (ComboMATCH);Clinical Cancer Research;2023-01-20
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3